Internal Medicine, Hematology & Oncology · Atlanta, GA
NPI
1568490852
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1800 Howell Mill Rd NW Ste 800
Atlanta, GA, 30318
Phone (404) 350-9853
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
142,037 services
Medicare patients, 2024
590
Average age 75
Drug cost, 2024
$3.7M
1,211 prescriptions
Company payments, 2025
$3,319
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay M Rhee was code J9271 (injection, pembrolizumab, 1 mg), 12,000 times for 20 patients. In total Jay M Rhee billed 142,037 services in 128 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,000 | 20 | $42.36 | $508K |
| J0897 Injection, denosumab, 1 mg | Office | 8,220 | 28 | $19.46 | $160K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,900 | 42 | $15.21 | $75K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,436 | 51 | $0.08 | $119 |
| 85025 Blood Count | Office | 1,127 | 358 | $7.59 | $8,553 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,120 | 11 | $5.96 | $6,671 |
| 99214 Office E&M - Established | Office | 555 | 133 | $88.18 | $49K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 500 | 17 | $0.68 | $338 |
| 99213 Office E&M - Established | Office | 444 | 219 | $57.08 | $25K |
| 96413 Chemotherapy Administration | Office | 352 | 120 | $92.08 | $32K |
| 96372 Injection Administration | Office | 337 | 96 | $9.93 | $3,347 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 280 | 16 | $0.24 | $67.02 |
| 96367 Intravenous Infusion, Hydration | Office | 215 | 53 | $19.99 | $4,298 |
| 96415 Chemotherapy Administration | Office | 136 | 38 | $18.70 | $2,544 |
| 96401 Chemotherapy Administration | Office | 130 | 16 | $50.96 | $6,625 |
By year: 2022 $2.9M for 143,267 services; 2023 $2.0M for 103,211 services; 2024 $2.9M for 142,037 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,127 | 358 | $7.59 | $8,553 |
Medicare prescription drug claims, 2024
In 2024, the drug Jay M Rhee prescribed most often to Medicare patients was Hydroxyurea, with 106 prescriptions and refills. In total Jay M Rhee wrote 1,211 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 106 | 213 | 23 | $2,752 |
| Eliquis Apixaban | 93 | 134 | 21 | $74K |
| Revlimid Lenalidomide | 67 | 67 | Under 11 | $1.3M |
| Oxycodone Hcl Generic | 63 | 63 | 24 | $866 |
| Anastrozole Generic | 56 | 146 | 18 | $784 |
| Prednisone Generic | 56 | 64 | 13 | $231 |
| Valacyclovir Valacyclovir Hcl | 53 | 69 | 14 | $1,495 |
| Dexamethasone Generic | 44 | 52 | 22 | $1,389 |
| Prochlorperazine Maleate Generic | 40 | 40 | 28 | $632 |
| Tamoxifen Citrate Generic | 32 | 54 | Under 11 | $573 |
| Xarelto Rivaroxaban | 27 | 53 | Under 11 | $29K |
| Imbruvica Ibrutinib | 26 | 26 | Under 11 | $412K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 23 | 23 | 21 | $257 |
| Udenyca Autoinjector Pegfilgrastim-Cbqv | 22 | 22 | Under 11 | $88K |
| Pomalyst Pomalidomide | 19 | 19 | Under 11 | $417K |
Brand drugs: - claims; generic drugs: 824 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay M Rhee $3,319 ($3,319 in general payments such as food, travel and fees) from 32 companies. The largest payer was Alphatec Spine, Inc with $764.
| Company | Payments | Amount |
|---|---|---|
| Alphatec Spine, Inc ATEC | 1 | $764 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $305 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $272 |
| Merck Sharp & Dohme LLC MRK | 9 | $255 |
| Pfizer Inc. PFE | 14 | $233 |
| Daiichi Sankyo Inc. 4568.T | 9 | $220 |
| Abbvie Inc. ABBV | 9 | $191 |
| Genzyme Corporation SNY | 5 | $152 |
| BeOne Medicines USA, Inc. ONC | 4 | $93 |
| Gilead Sciences, Inc. GILD | 4 | $90 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.